The Johns Hopkins Hospital
600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287
Johns Hopkins Medicine - Green Spring Station
2360 W. Joppa Road
Lutherville, MD 21093
Celiac Disease, Clinical Gastroenterology, Colitis, Crohn's Disease, Diarrhea, Digestive Diseases, Gastroenterology, Inflammatory Bowel Disease, Proctitis, Ulcerative Colitis
Genetics of Inflammatory Bowel Disease
Dr. Steven Brant is an Associate Professor of Medicine at Johns Hopkins Hospital, Division of Gastroenterology. He is Director of the Meyerhoff Inflammatory Bowel Disease Center at Johns Hopkins, and he is the Director of the Meyerhoff Inflammatory Bowel Disease Genetics Laboratory.
His special interests are the genetics and genetic epidemiology of inflammatory bowel disease, Crohns disease and ulcerative colitis. His clinical interests are treatment of inflammatory bowel disease. Dr. Brant is a graduate of the University of Florida College of Medicine. He did internal medicine internship and residency at Indiana University Medical Center in Indianapolis completed in 1989. His gastroenterology training was at Johns Hopkins Hospital, completed in 1992.
Dr. Brant has been on the faculty as part of the Gastroenterology Division at Johns Hopkins since 1992. He holds a joint appointment in the Johns Hopkins Bloomberg School of Public Health. He has authored more than 50 scientific papers, and has contributed to several book chapters. He is an Associate Editor for the journal, Inflammatory Bowel Disease.
Dr. Brant has been at the forefront of the efforts to identify genes for inflammatory bowel disease, and he has been involved with the discovery of several Crohns disease genes. His laboratory serves as one of the Genetic Research Centers (GRC) for the National Institutes of Health Inflammatory Bowel Disease Genetics Consortium. In this effort, Dr. Brant is leading investigations on the genetics of inflammatory bowel disease in African Americans and Ashkenazi Jews. He has also led clinical investigations of comparisons of disease treatments and health outcomes of IBD by race. He has developed quality control measures for medical management of IBD and prevention of complications.